Resona Asset Management Co. Ltd. bought a new stake in The Allstate Co. (NYSE:ALL – Free Report) during the 4th quarter, Holdings Channel reports. The institutional investor bought 93,285 shares of the insurance provider’s stock, valued at approximately $17,996,000.
A number of other hedge funds and other institutional investors also recently bought and sold shares of ALL. Apella Capital LLC raised its position in shares of Allstate by 1.9% during the 4th quarter. Apella Capital LLC now owns 3,231 shares of the insurance provider’s stock worth $623,000 after acquiring an additional 60 shares in the last quarter. Intrust Bank NA raised its holdings in Allstate by 0.5% during the fourth quarter. Intrust Bank NA now owns 12,135 shares of the insurance provider’s stock worth $2,340,000 after purchasing an additional 61 shares in the last quarter. Perigon Wealth Management LLC lifted its position in shares of Allstate by 2.1% during the 4th quarter. Perigon Wealth Management LLC now owns 2,990 shares of the insurance provider’s stock worth $571,000 after buying an additional 62 shares during the last quarter. Mather Group LLC. boosted its holdings in shares of Allstate by 1.7% in the 4th quarter. Mather Group LLC. now owns 3,616 shares of the insurance provider’s stock valued at $697,000 after buying an additional 62 shares in the last quarter. Finally, Angeles Wealth Management LLC grew its position in shares of Allstate by 4.6% in the 4th quarter. Angeles Wealth Management LLC now owns 1,403 shares of the insurance provider’s stock valued at $270,000 after buying an additional 62 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Allstate Stock Down 9.1 %
Allstate stock opened at $186.74 on Friday. The stock’s 50 day moving average price is $197.37 and its 200 day moving average price is $194.35. The company has a market cap of $49.49 billion, a PE ratio of 10.99, a price-to-earnings-growth ratio of 1.01 and a beta of 0.47. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.36 and a quick ratio of 0.40. The Allstate Co. has a 1-year low of $156.66 and a 1-year high of $212.91.
Allstate announced that its Board of Directors has approved a share buyback plan on Wednesday, February 26th that allows the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization allows the insurance provider to repurchase up to 3% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s management believes its shares are undervalued.
Allstate Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Stockholders of record on Monday, March 10th were paid a dividend of $1.00 per share. This is a positive change from Allstate’s previous quarterly dividend of $0.92. The ex-dividend date was Monday, March 10th. This represents a $4.00 annualized dividend and a dividend yield of 2.14%. Allstate’s payout ratio is 23.54%.
Insider Buying and Selling
In other Allstate news, CFO Jesse E. Merten sold 40,102 shares of the business’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the sale, the chief financial officer now directly owns 18,115 shares in the company, valued at approximately $3,378,990.95. The trade was a 68.88 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.80% of the company’s stock.
Analyst Upgrades and Downgrades
ALL has been the subject of several research analyst reports. Barclays decreased their price objective on shares of Allstate from $187.00 to $183.00 and set an “underweight” rating for the company in a research note on Monday, January 6th. Evercore ISI upgraded Allstate from an “in-line” rating to an “outperform” rating in a research note on Wednesday, January 8th. StockNews.com cut Allstate from a “buy” rating to a “hold” rating in a research note on Monday, March 31st. Keefe, Bruyette & Woods raised their target price on shares of Allstate from $235.00 to $240.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 11th. Finally, Argus upgraded shares of Allstate from a “hold” rating to a “buy” rating in a research report on Monday, March 3rd. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $219.80.
Read Our Latest Stock Report on ALL
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
- Five stocks we like better than Allstate
- 3 Healthcare Dividend Stocks to Buy
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Airline Stocks – Top Airline Stocks to Buy Now
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Health Care Stocks Explained: Why You Might Want to Invest
- Spotify Stock Eyes Double-Digit UpsideāIs Now the Time to Buy?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.